Rubric Capital Management LP Roivant Sciences Ltd. Transaction History
Rubric Capital Management LP
- $3.59 Billion
- Q3 2024
A detailed history of Rubric Capital Management LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Rubric Capital Management LP holds 22,400,000 shares of ROIV stock, worth $268 Million. This represents 7.2% of its overall portfolio holdings.
Number of Shares
22,400,000
Previous 23,000,000
2.61%
Holding current value
$268 Million
Previous $243 Million
6.33%
% of portfolio
7.2%
Previous 7.2%
Shares
8 transactions
Others Institutions Holding ROIV
# of Institutions
310Shares Held
507MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$789 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$788 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$648 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$499 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$423 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.43B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...